Clinical Trial Update: Treatment of Chronic Obstructive Pulmonary Disease (COPD) With Iodinated Activated Charcoal [Phase 2]

View source ↗

Summary

Reports on a completed Phase 2 trial evaluating iodinated activated charcoal for chronic obstructive pulmonary disease. The sponsor is PharmaLundensis AB.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Iodinated Activated Charcoal (Iodinated Activated Charcoal)

Snippet

Sponsor: PharmaLundensis AB | Conditions: Chronic Obstructive Lung Disease | Phase 2 | Status: COMPLETED